The anti-inflammatory effect of ginseng and ginsenosides in the treatment of COPD includes regulating the NF-κB pathway, and inflammatory cytokine (TNF-α, IL-6, IL-8, and IL-1β) expressions (Shergis et al., 2014). Here, IL1B is linked to chronic obstructive pulmonary disease.